According to these results, chitosan salicylaldehyde/CuFe2O4 may have a greater impact than chitosan salicylaldehyde in reducing the expression of PI3K, AKT, mTOR, and Cyclin D1, which in turn prevents the survival and proliferation of PC3 prostate cancer cells66. Here, CCND1 is linked to prostate carcinoma.